Transparent communication - Annual report 2014
The annual report “Transparent communication - Annual report 2014” is available :
♦ in English : Newspaper (PDF, 2.11 MB) - Annual Report 2014 (PDF, 6.86 MB) - Flipbook
♦ in French : Newspaper (PDF, 2.17 MB) - Rapport annuel 2014 (PDF, 6.42 MB) - Flipbook
♦ in Dutch : Newspaper (PDF, 2.17 MB) - Jaarverslag 2014 (PDF, 6.49 MB) - Flipbook
You can also ask for a paper copy of this annual report (as long as available) by mail to: email@example.com
Les médicaments génériques sont aussi de qualité, sûrs et efficaces.
The famhp is actively involved in the management of the Ebola dossier:
Read more on the role of the famhp.
More information on:
Information for the public
The federal agency for medicines and health products (famhp) published its annual report 2014 today.read more
To the attention of holders of MA’s: new definition for the approval date mentioned in SmPC and PIL.
When the administratively closing of a variation or renewal leads to an update of the marketing authorization (MA), a new methodology to determine the approval date mentioned in the summary of product characteristics (SmPC) and patient leaflet (PIL) will be used from 15/6/15.read more
The new edition of the electronic newsletter "VIG-NEWS" of the federal agency for medicines and health products (famhp) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.read more
Links to pages and documents useful for healthcare professionals
- Direct Healthcare Professional
- Field Safety Notices concerning
- Therapeutic Magistral Form (TMF)
- Unavailability of medicinal products
- RMA-materials (Risk Minimisation Activities)
- International Nonproprietary Name (INN) prescription and substitution
- Withdrawal periods (medicines for veterinary use)